Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-4
|
ENSMUSG00000054160.2 | NK2 homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_147074097_147074259 | Nkx2-4 | 11267 | 0.186857 | -0.39 | 3.3e-03 | Click! |
chr2_147083849_147084129 | Nkx2-4 | 1456 | 0.417420 | -0.08 | 5.8e-01 | Click! |
chr2_147084950_147085101 | Nkx2-4 | 420 | 0.844929 | -0.06 | 6.4e-01 | Click! |
chr2_147084285_147084436 | Nkx2-4 | 1085 | 0.523166 | -0.04 | 7.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_8500924_8501101 | 17.90 |
Tns3 |
tensin 3 |
32337 |
0.24 |
chr19_59844292_59844601 | 16.42 |
Gm17203 |
predicted gene 17203 |
56616 |
0.13 |
chr19_6969291_6970359 | 13.82 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr12_17318527_17318803 | 13.06 |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
6000 |
0.16 |
chr13_72593983_72594149 | 12.56 |
Gm20554 |
predicted gene, 20554 |
34498 |
0.16 |
chr10_58972209_58972479 | 12.04 |
Gm27672 |
predicted gene, 27672 |
6801 |
0.27 |
chr9_25385405_25385556 | 11.68 |
Gm18891 |
predicted gene, 18891 |
35982 |
0.15 |
chr2_122109778_122110051 | 11.55 |
Spg11 |
SPG11, spatacsin vesicle trafficking associated |
8382 |
0.15 |
chr13_95484776_95484950 | 11.30 |
S100z |
S100 calcium binding protein, zeta |
6142 |
0.17 |
chr6_34903572_34903758 | 11.07 |
Wdr91 |
WD repeat domain 91 |
6898 |
0.13 |
chr5_137921592_137921941 | 10.87 |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
147 |
0.9 |
chr8_13540244_13540395 | 10.79 |
Gm5608 |
predicted gene 5608 |
6709 |
0.16 |
chr16_15368187_15368354 | 10.76 |
Gm21897 |
predicted gene, 21897 |
50812 |
0.13 |
chr5_121570090_121570241 | 10.68 |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
1022 |
0.34 |
chr10_98704696_98704847 | 10.67 |
Gm5427 |
predicted gene 5427 |
5061 |
0.33 |
chr2_73591985_73592312 | 10.46 |
Chn1os3 |
chimerin 1, opposite strand 3 |
4378 |
0.16 |
chr13_63117485_63117672 | 10.46 |
Aopep |
aminopeptidase O |
10056 |
0.15 |
chr11_59645145_59645320 | 10.44 |
Mprip |
myosin phosphatase Rho interacting protein |
16073 |
0.12 |
chr11_120686724_120686911 | 10.32 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
124 |
0.88 |
chr13_28751184_28751354 | 9.87 |
Mir6368 |
microRNA 6368 |
40396 |
0.17 |
chr8_46073906_46074060 | 9.82 |
Snx25 |
sorting nexin 25 |
6301 |
0.16 |
chr7_129672413_129672605 | 9.64 |
Gm33248 |
predicted gene, 33248 |
5084 |
0.23 |
chr11_109059985_109060145 | 9.61 |
Gm24149 |
predicted gene, 24149 |
7025 |
0.22 |
chr13_111516876_111517063 | 9.44 |
Gpbp1 |
GC-rich promoter binding protein 1 |
26858 |
0.12 |
chr5_114370337_114370819 | 9.42 |
Kctd10 |
potassium channel tetramerisation domain containing 10 |
371 |
0.81 |
chr14_20768613_20768995 | 9.41 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
3295 |
0.15 |
chr5_99420004_99420179 | 9.36 |
Gm35172 |
predicted gene, 35172 |
88298 |
0.08 |
chr1_79932415_79932709 | 9.27 |
Gm5529 |
predicted pseudogene 5529 |
9136 |
0.21 |
chr5_46086980_46087150 | 9.25 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
154656 |
0.04 |
chr7_127768560_127769629 | 9.14 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr9_123519628_123519797 | 9.06 |
Limd1 |
LIM domains containing 1 |
1973 |
0.3 |
chr11_109175541_109175880 | 9.05 |
Gm11658 |
predicted gene 11658 |
15516 |
0.19 |
chr7_99553773_99554081 | 9.04 |
Mir326 |
microRNA 326 |
1658 |
0.25 |
chr18_37891294_37891482 | 8.97 |
Diaph1 |
diaphanous related formin 1 |
6554 |
0.1 |
chr10_95458490_95458769 | 8.91 |
Gm47599 |
predicted gene, 47599 |
2595 |
0.17 |
chr12_85779033_85779184 | 8.91 |
Flvcr2 |
feline leukemia virus subgroup C cellular receptor 2 |
4278 |
0.18 |
chr7_118723973_118724131 | 8.90 |
Ccp110 |
centriolar coiled coil protein 110 |
1913 |
0.22 |
chr8_128219019_128219170 | 8.88 |
Mir21c |
microRNA 21c |
59131 |
0.15 |
chr3_121531237_121531694 | 8.74 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
154 |
0.91 |
chr13_41958037_41958226 | 8.73 |
Gm22157 |
predicted gene, 22157 |
56480 |
0.11 |
chr9_71663389_71664022 | 8.71 |
Cgnl1 |
cingulin-like 1 |
15355 |
0.21 |
chr2_58829260_58829587 | 8.70 |
Gm11099 |
predicted gene 11099 |
30011 |
0.17 |
chr10_96499329_96499480 | 8.68 |
Gm8601 |
predicted gene 8601 |
22925 |
0.17 |
chr3_89280469_89281651 | 8.67 |
Efna1 |
ephrin A1 |
82 |
0.91 |
chr2_148018222_148018401 | 8.61 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
19959 |
0.17 |
chr9_94752218_94752549 | 8.58 |
Mir7656 |
microRNA 7656 |
554 |
0.81 |
chr9_61596825_61596976 | 8.55 |
Gm34424 |
predicted gene, 34424 |
63485 |
0.12 |
chr3_97076076_97076280 | 8.55 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16607 |
0.15 |
chr15_77893444_77893605 | 8.52 |
Txn2 |
thioredoxin 2 |
22176 |
0.13 |
chr4_82793733_82793884 | 8.48 |
Zdhhc21 |
zinc finger, DHHC domain containing 21 |
57006 |
0.12 |
chr9_53325826_53325981 | 8.47 |
Exph5 |
exophilin 5 |
15181 |
0.18 |
chr6_51170890_51171264 | 8.44 |
Mir148a |
microRNA 148a |
98833 |
0.07 |
chr5_135522543_135522694 | 8.29 |
Hip1 |
huntingtin interacting protein 1 |
22497 |
0.12 |
chr19_18758258_18758409 | 8.26 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
292 |
0.9 |
chr5_52748746_52748897 | 8.26 |
Pi4k2b |
phosphatidylinositol 4-kinase type 2 beta |
5781 |
0.21 |
chr10_84610774_84611116 | 8.24 |
Gm25657 |
predicted gene, 25657 |
3774 |
0.16 |
chr3_98410923_98411117 | 8.24 |
Zfp697 |
zinc finger protein 697 |
28472 |
0.12 |
chr7_74080485_74080708 | 8.23 |
Gm45004 |
predicted gene 45004 |
36858 |
0.17 |
chr12_100323780_100323931 | 8.23 |
Ttc7b |
tetratricopeptide repeat domain 7B |
9054 |
0.18 |
chr8_91807094_91807245 | 8.21 |
Irx3os |
iroquois homeobox 3, opposite strand |
4994 |
0.16 |
chr1_41420569_41420756 | 8.18 |
Gm28634 |
predicted gene 28634 |
108881 |
0.08 |
chr13_47193398_47193561 | 8.17 |
Rnf144b |
ring finger protein 144B |
346 |
0.87 |
chr8_91489210_91489361 | 8.16 |
Gm45289 |
predicted gene 45289 |
3734 |
0.17 |
chr1_125013472_125013798 | 8.14 |
Dpp10 |
dipeptidylpeptidase 10 |
167596 |
0.04 |
chr19_42145371_42145532 | 8.10 |
Marveld1 |
MARVEL (membrane-associating) domain containing 1 |
1949 |
0.21 |
chr8_83520776_83520927 | 8.06 |
Olfr370 |
olfactory receptor 370 |
14929 |
0.1 |
chr10_59364658_59364824 | 8.02 |
Gm10273 |
predicted pseudogene 10273 |
31014 |
0.14 |
chr2_44146528_44146679 | 8.00 |
Arhgap15os |
Rho GTPase activating protein 15, opposite strand |
81279 |
0.1 |
chr6_72304496_72304655 | 7.96 |
Sftpb |
surfactant associated protein B |
35 |
0.96 |
chr6_99276059_99276210 | 7.96 |
Foxp1 |
forkhead box P1 |
9602 |
0.29 |
chr12_110123062_110123213 | 7.96 |
3110009F21Rik |
RIKEN cDNA 3110009F21 gene |
34940 |
0.09 |
chr11_100782251_100782402 | 7.91 |
Ghdc |
GH3 domain containing |
11369 |
0.1 |
chr4_142221224_142221954 | 7.82 |
Kazn |
kazrin, periplakin interacting protein |
11383 |
0.22 |
chr1_151624884_151625035 | 7.81 |
Fam129a |
family with sequence similarity 129, member A |
52208 |
0.11 |
chr14_65737090_65737241 | 7.80 |
Scara5 |
scavenger receptor class A, member 5 |
60688 |
0.1 |
chr17_6835585_6835736 | 7.79 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
27151 |
0.13 |
chr1_182905957_182906108 | 7.75 |
Gm37542 |
predicted gene, 37542 |
1678 |
0.42 |
chr8_44709121_44709434 | 7.74 |
Gm26089 |
predicted gene, 26089 |
107444 |
0.07 |
chr2_11424350_11424501 | 7.73 |
Gm13296 |
predicted gene 13296 |
4201 |
0.13 |
chr1_181975025_181975257 | 7.70 |
Gm38359 |
predicted gene, 38359 |
5218 |
0.15 |
chr6_91389110_91389432 | 7.69 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
22092 |
0.11 |
chr7_28597227_28598470 | 7.67 |
Pak4 |
p21 (RAC1) activated kinase 4 |
238 |
0.53 |
chr2_116942185_116942336 | 7.64 |
Gm25514 |
predicted gene, 25514 |
25913 |
0.15 |
chr8_124691734_124691926 | 7.64 |
Ttc13 |
tetratricopeptide repeat domain 13 |
9300 |
0.15 |
chr7_109736306_109736457 | 7.60 |
Ascl3 |
achaete-scute family bHLH transcription factor 3 |
4655 |
0.11 |
chr13_81089992_81090512 | 7.54 |
Gm18517 |
predicted gene, 18517 |
2688 |
0.21 |
chr7_143188732_143188883 | 7.53 |
Gm28821 |
predicted gene 28821 |
48199 |
0.09 |
chr11_109681669_109681823 | 7.53 |
Fam20a |
family with sequence similarity 20, member A |
1233 |
0.44 |
chr9_75546994_75547145 | 7.52 |
Tmod3 |
tropomodulin 3 |
5362 |
0.16 |
chr1_40375336_40375487 | 7.50 |
Gm17970 |
predicted gene, 17970 |
21559 |
0.17 |
chr9_77966979_77967139 | 7.48 |
Gm34829 |
predicted gene, 34829 |
25540 |
0.11 |
chr3_121560117_121560450 | 7.46 |
Slc44a3 |
solute carrier family 44, member 3 |
27879 |
0.14 |
chr6_34903967_34904145 | 7.41 |
Wdr91 |
WD repeat domain 91 |
6507 |
0.13 |
chr7_139409960_139410484 | 7.38 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
9733 |
0.25 |
chr4_129391261_129391419 | 7.36 |
Gm12980 |
predicted gene 12980 |
11496 |
0.11 |
chr8_11260294_11260445 | 7.34 |
Col4a1 |
collagen, type IV, alpha 1 |
14764 |
0.16 |
chr7_108993297_108993451 | 7.34 |
Tub |
tubby bipartite transcription factor |
17451 |
0.14 |
chr16_38648886_38649064 | 7.33 |
Gm15530 |
predicted gene 15530 |
36894 |
0.12 |
chr11_96551023_96551222 | 7.30 |
Skap1 |
src family associated phosphoprotein 1 |
61261 |
0.09 |
chr2_110294800_110295277 | 7.29 |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
10703 |
0.22 |
chr15_77832174_77832343 | 7.27 |
Gm22107 |
predicted gene, 22107 |
8498 |
0.15 |
chr3_102231805_102231971 | 7.24 |
Gm43241 |
predicted gene 43241 |
17781 |
0.14 |
chr6_55256444_55256791 | 7.23 |
Mindy4 |
MINDY lysine 48 deubiquitinase 4 |
21538 |
0.16 |
chr7_75399540_75399730 | 7.20 |
Gm44962 |
predicted gene 44962 |
21500 |
0.16 |
chr8_34601688_34601839 | 7.17 |
Gm34096 |
predicted gene, 34096 |
6542 |
0.2 |
chr10_111672871_111673087 | 7.15 |
Gm47864 |
predicted gene, 47864 |
23167 |
0.15 |
chr7_83966489_83966714 | 7.14 |
Cemip |
cell migration inducing protein, hyaluronan binding |
9474 |
0.18 |
chr6_38108597_38108750 | 7.14 |
Tmem213 |
transmembrane protein 213 |
582 |
0.54 |
chr9_14544447_14544660 | 7.10 |
Amotl1 |
angiomotin-like 1 |
14498 |
0.12 |
chr3_102743229_102743380 | 7.10 |
Tspan2os |
tetraspanin 2, opposite strand |
7887 |
0.12 |
chr8_41397237_41397401 | 7.07 |
Frg1 |
FSHD region gene 1 |
15603 |
0.22 |
chrX_104013532_104013714 | 7.04 |
Gm23378 |
predicted gene, 23378 |
12144 |
0.14 |
chr9_61164915_61165148 | 7.03 |
I730028E13Rik |
RIKEN cDNA I730028E13 gene |
26516 |
0.14 |
chr14_76448983_76449138 | 7.02 |
Tsc22d1 |
TSC22 domain family, member 1 |
10127 |
0.25 |
chr13_119613872_119614873 | 7.01 |
Gm48265 |
predicted gene, 48265 |
900 |
0.48 |
chr11_120744053_120744204 | 7.00 |
Cbr2 |
carbonyl reductase 2 |
12014 |
0.06 |
chr14_87019764_87019915 | 6.99 |
Gm23438 |
predicted gene, 23438 |
99128 |
0.07 |
chr13_89122641_89122807 | 6.98 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
301082 |
0.01 |
chr16_92674190_92674488 | 6.98 |
Runx1 |
runt related transcription factor 1 |
21156 |
0.21 |
chr9_118975424_118975656 | 6.98 |
Ctdspl |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
45673 |
0.1 |
chr6_92854831_92854982 | 6.98 |
Adamts9 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 |
274 |
0.92 |
chr18_14481565_14481716 | 6.97 |
Gm50098 |
predicted gene, 50098 |
10365 |
0.23 |
chr5_119480394_119480588 | 6.97 |
Gm31314 |
predicted gene, 31314 |
47463 |
0.15 |
chr14_58273799_58273961 | 6.96 |
Gm33321 |
predicted gene, 33321 |
27093 |
0.2 |
chr8_64221721_64221872 | 6.95 |
Tll1 |
tolloid-like |
15525 |
0.25 |
chr3_90088771_90088922 | 6.95 |
Tpm3 |
tropomyosin 3, gamma |
785 |
0.41 |
chr4_139386785_139387002 | 6.91 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
6224 |
0.12 |
chr7_47100758_47100922 | 6.91 |
Ptpn5 |
protein tyrosine phosphatase, non-receptor type 5 |
9504 |
0.1 |
chr11_98187777_98187928 | 6.90 |
Gm11604 |
predicted gene 11604 |
2486 |
0.17 |
chr11_51396531_51396814 | 6.90 |
Col23a1 |
collagen, type XXIII, alpha 1 |
106752 |
0.05 |
chr8_36677917_36678123 | 6.89 |
Dlc1 |
deleted in liver cancer 1 |
55034 |
0.16 |
chr13_99124811_99124962 | 6.89 |
Gm807 |
predicted gene 807 |
24125 |
0.16 |
chr15_79956647_79957055 | 6.87 |
Cbx7 |
chromobox 7 |
14267 |
0.12 |
chr12_80227881_80228197 | 6.87 |
Gm47767 |
predicted gene, 47767 |
18796 |
0.13 |
chr8_123185966_123186117 | 6.87 |
Dpep1 |
dipeptidase 1 |
201 |
0.84 |
chr6_97252684_97252973 | 6.86 |
Lmod3 |
leiomodin 3 (fetal) |
69 |
0.97 |
chr4_137081482_137081633 | 6.83 |
Zbtb40 |
zinc finger and BTB domain containing 40 |
32756 |
0.11 |
chr9_63909669_63910017 | 6.83 |
Gm18541 |
predicted gene, 18541 |
11578 |
0.19 |
chr5_151251706_151251981 | 6.79 |
5430435K18Rik |
RIKEN cDNA 5430435K18 gene |
462 |
0.82 |
chr7_136390134_136390285 | 6.75 |
Gm36849 |
predicted gene, 36849 |
36845 |
0.17 |
chr2_163345083_163345234 | 6.75 |
Tox2 |
TOX high mobility group box family member 2 |
24780 |
0.15 |
chr2_16147962_16148326 | 6.74 |
Gm37416 |
predicted gene, 37416 |
124719 |
0.06 |
chr17_12180104_12180316 | 6.72 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
9711 |
0.19 |
chr9_42206799_42206960 | 6.72 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
2334 |
0.3 |
chr8_45855274_45855425 | 6.70 |
Gm25309 |
predicted gene, 25309 |
9254 |
0.14 |
chr8_36685476_36685694 | 6.63 |
Dlc1 |
deleted in liver cancer 1 |
47469 |
0.18 |
chr2_61114040_61114193 | 6.63 |
Gm13579 |
predicted gene 13579 |
83146 |
0.09 |
chr8_34601527_34601678 | 6.62 |
Gm34096 |
predicted gene, 34096 |
6703 |
0.2 |
chr11_89672465_89672620 | 6.62 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
24303 |
0.27 |
chr6_14700114_14700406 | 6.60 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
55014 |
0.17 |
chr4_57067049_57067200 | 6.57 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
3435 |
0.29 |
chr8_39313888_39314079 | 6.57 |
Gm18644 |
predicted gene, 18644 |
2289 |
0.3 |
chr9_48708110_48708261 | 6.55 |
Nnmt |
nicotinamide N-methyltransferase |
103032 |
0.06 |
chr10_66752330_66752675 | 6.54 |
Gm47895 |
predicted gene, 47895 |
6952 |
0.16 |
chr4_119535216_119535367 | 6.54 |
Frg2f1 |
FSHD region gene 2 family member 1 |
46 |
0.94 |
chr13_37657358_37657585 | 6.51 |
AI463229 |
expressed sequence AI463229 |
9071 |
0.12 |
chr5_111890798_111891136 | 6.51 |
Gm42488 |
predicted gene 42488 |
53268 |
0.14 |
chr6_95841670_95841821 | 6.49 |
Gm7838 |
predicted gene 7838 |
85184 |
0.1 |
chr7_110088063_110088458 | 6.46 |
Zfp143 |
zinc finger protein 143 |
3369 |
0.16 |
chr11_105310185_105310476 | 6.46 |
Mrc2 |
mannose receptor, C type 2 |
17662 |
0.18 |
chr10_45079834_45080145 | 6.45 |
Prep |
prolyl endopeptidase |
12786 |
0.17 |
chr13_20905268_20905445 | 6.44 |
Gm25605 |
predicted gene, 25605 |
60602 |
0.11 |
chr19_29930423_29930574 | 6.42 |
Il33 |
interleukin 33 |
5366 |
0.21 |
chr10_61386219_61386644 | 6.40 |
Pald1 |
phosphatase domain containing, paladin 1 |
2901 |
0.16 |
chr18_80094753_80094904 | 6.37 |
Gm21886 |
predicted gene, 21886 |
4866 |
0.11 |
chr4_143099741_143099892 | 6.37 |
6330411D24Rik |
RIKEN cDNA 6330411D24 gene |
24977 |
0.15 |
chr2_35287134_35287310 | 6.35 |
Gsn |
gelsolin |
4709 |
0.16 |
chr15_7216087_7216238 | 6.35 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
6907 |
0.28 |
chr3_27103133_27103284 | 6.28 |
Gm25152 |
predicted gene, 25152 |
5774 |
0.18 |
chr17_49641995_49642146 | 6.28 |
Kif6 |
kinesin family member 6 |
26898 |
0.22 |
chr13_3750985_3751146 | 6.27 |
Gm47695 |
predicted gene, 47695 |
8760 |
0.15 |
chr6_84932962_84933291 | 6.27 |
Gm44012 |
predicted gene, 44012 |
12003 |
0.2 |
chr11_75053264_75053415 | 6.26 |
Gm12335 |
predicted gene 12335 |
13423 |
0.12 |
chr2_4648419_4648570 | 6.24 |
Prpf18 |
pre-mRNA processing factor 18 |
3587 |
0.25 |
chr15_100318794_100318945 | 6.24 |
Mettl7a1 |
methyltransferase like 7A1 |
13698 |
0.1 |
chr11_89996960_89997147 | 6.23 |
Pctp |
phosphatidylcholine transfer protein |
5841 |
0.26 |
chr8_13828914_13829081 | 6.23 |
AF366264 |
cDNA sequence AF366264 |
9392 |
0.13 |
chr6_97356696_97356847 | 6.21 |
Frmd4b |
FERM domain containing 4B |
2594 |
0.35 |
chr19_24042488_24042639 | 6.21 |
Fam189a2 |
family with sequence similarity 189, member A2 |
11544 |
0.17 |
chr9_119926488_119926652 | 6.20 |
Wdr48 |
WD repeat domain 48 |
5272 |
0.13 |
chr17_14401117_14401268 | 6.20 |
Smoc2 |
SPARC related modular calcium binding 2 |
406 |
0.81 |
chr11_105933914_105934065 | 6.18 |
Cyb561 |
cytochrome b-561 |
2188 |
0.21 |
chr10_45180768_45180992 | 6.17 |
Popdc3 |
popeye domain containing 3 |
2782 |
0.28 |
chr18_13636789_13636951 | 6.17 |
AC103362.1 |
novel transcript |
35470 |
0.23 |
chr14_86309180_86309331 | 6.17 |
Gm23926 |
predicted gene, 23926 |
2123 |
0.23 |
chr8_88357666_88357817 | 6.14 |
Brd7 |
bromodomain containing 7 |
4273 |
0.23 |
chr5_136053337_136053488 | 6.13 |
Upk3bl |
uroplakin 3B-like |
1080 |
0.34 |
chr18_63136605_63136791 | 6.13 |
Piezo2 |
piezo-type mechanosensitive ion channel component 2 |
8430 |
0.24 |
chr5_66784745_66784906 | 6.12 |
Limch1 |
LIM and calponin homology domains 1 |
38936 |
0.13 |
chr17_12734325_12734532 | 6.11 |
Airn |
antisense Igf2r RNA |
6883 |
0.15 |
chr13_98695132_98695882 | 6.11 |
Tmem171 |
transmembrane protein 171 |
673 |
0.61 |
chr1_135835745_135836286 | 6.09 |
Tnnt2 |
troponin T2, cardiac |
339 |
0.83 |
chr15_102188216_102188451 | 6.09 |
Csad |
cysteine sulfinic acid decarboxylase |
236 |
0.86 |
chr7_27232781_27233338 | 6.07 |
Coq8b |
coenzyme Q8B |
36 |
0.93 |
chr1_186307759_186307910 | 6.07 |
Gm37491 |
predicted gene, 37491 |
39481 |
0.19 |
chr16_57403860_57404011 | 6.06 |
Filip1l |
filamin A interacting protein 1-like |
50658 |
0.12 |
chr9_47414695_47414893 | 6.05 |
Gm31816 |
predicted gene, 31816 |
46145 |
0.14 |
chr3_149811186_149811406 | 6.04 |
Gm31121 |
predicted gene, 31121 |
150900 |
0.04 |
chr8_126768182_126768461 | 6.04 |
Gm45805 |
predicted gene 45805 |
9987 |
0.24 |
chr2_133783735_133783902 | 6.03 |
Gm25258 |
predicted gene, 25258 |
199397 |
0.03 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 11.7 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.9 | 9.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 5.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.7 | 5.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.7 | 5.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.7 | 5.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.6 | 7.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.6 | 1.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.5 | 6.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.4 | 8.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.4 | 11.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.4 | 2.7 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
1.4 | 1.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.3 | 3.9 | GO:0001757 | somite specification(GO:0001757) |
1.3 | 3.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.3 | 6.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 5.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.2 | 3.7 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.2 | 4.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.2 | 2.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.2 | 2.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.2 | 2.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.1 | 3.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.1 | 5.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.1 | 3.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 3.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.1 | 3.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.1 | 2.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.1 | 6.4 | GO:1902946 | protein localization to early endosome(GO:1902946) |
1.1 | 5.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.1 | 5.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.0 | 4.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.0 | 3.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 4.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.0 | 3.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.0 | 2.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.0 | 3.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.0 | 11.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
1.0 | 3.9 | GO:0072319 | vesicle uncoating(GO:0072319) |
1.0 | 2.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
1.0 | 3.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 1.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 2.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 3.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.9 | 2.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 2.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 2.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.9 | 3.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 3.4 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.8 | 5.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 2.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.8 | 2.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.8 | 3.3 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 3.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 2.4 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.8 | 3.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.8 | 2.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 2.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.8 | 4.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.8 | 1.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.8 | 2.4 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.8 | 1.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.8 | 1.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.8 | 4.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 2.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 1.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.8 | 2.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.8 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 5.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.7 | 1.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.7 | 3.7 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.7 | 4.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 7.3 | GO:0060013 | righting reflex(GO:0060013) |
0.7 | 2.2 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 1.4 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.7 | 2.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.7 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.7 | 2.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 1.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.7 | 1.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 7.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.7 | 2.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.7 | 1.4 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.7 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.7 | 1.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 1.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 6.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.7 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 2.1 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.7 | 1.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 2.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.7 | 2.7 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.7 | 2.0 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.7 | 5.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.7 | 2.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.7 | 2.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.7 | 4.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.7 | 2.0 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.7 | 2.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 1.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 2.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 0.7 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.7 | 0.7 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.6 | 1.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.6 | 1.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 1.9 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.6 | 1.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.6 | 1.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.6 | 1.9 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.6 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 2.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 3.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 1.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 3.1 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 1.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.6 | 5.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 3.1 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.6 | 0.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.6 | 0.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 2.4 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.6 | 3.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.6 | 1.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 0.6 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.6 | 2.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 3.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.6 | 1.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.6 | 1.2 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 1.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 1.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 1.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 4.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 1.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 1.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 1.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 1.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.6 | 1.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.6 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 1.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 2.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.6 | 2.8 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.6 | 2.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.5 | 1.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 0.5 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.5 | 1.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 2.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 2.7 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.5 | 1.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 1.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 2.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.5 | 2.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.5 | 3.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 4.8 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.5 | 2.7 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 1.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 1.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.5 | 1.6 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 14.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.5 | 2.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 2.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 2.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 2.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 1.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 2.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 2.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 2.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 2.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 2.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.5 | 3.0 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.5 | 1.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 1.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 2.0 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.5 | 1.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.5 | 2.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 4.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.5 | 2.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 4.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.5 | 2.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 1.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 2.9 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 1.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.5 | 1.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.5 | 0.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.5 | 0.5 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.5 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.5 | 5.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 1.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 1.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 1.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.9 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 1.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 0.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 0.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 3.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 3.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 1.9 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 1.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 1.9 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 1.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 1.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.5 | 0.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.5 | 6.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 2.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.5 | 1.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 0.9 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.5 | 1.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 1.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 1.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 5.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 4.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 2.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 1.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 3.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 2.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 2.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 0.9 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.4 | 1.3 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 0.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 5.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 3.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 2.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 0.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.4 | 0.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 1.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 0.9 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.4 | 1.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.4 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 0.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.4 | 1.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.4 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.4 | 2.5 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.4 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.4 | 0.8 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.4 | 1.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 0.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 0.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 2.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.4 | 2.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.4 | 2.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 2.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 2.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.4 | 1.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 1.2 | GO:0046959 | habituation(GO:0046959) |
0.4 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.4 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.4 | 0.8 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 1.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 0.4 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 2.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 1.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 0.8 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.4 | 0.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 3.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 1.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 8.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 1.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.4 | 1.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 2.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 2.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 0.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 3.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 4.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.4 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.4 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 0.8 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.4 | 3.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.4 | 1.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.4 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 0.4 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.4 | 2.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 1.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.4 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 1.1 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.4 | 1.5 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 1.9 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.4 | 3.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.4 | 1.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 2.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 1.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 0.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 1.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 1.1 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 1.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 1.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 1.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 1.8 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.4 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 2.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.4 | 2.5 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 8.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 5.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 1.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.3 | 3.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 5.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 3.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 1.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 3.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 0.7 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 2.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 1.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 10.8 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 3.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 1.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.3 | 2.3 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.3 | 3.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 2.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 0.7 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 0.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 1.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.3 | 2.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 1.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 1.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 0.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.3 | 2.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.3 | 1.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.3 | 1.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 1.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 1.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 2.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 0.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 0.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 0.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 0.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 2.1 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.3 | 2.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.6 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 2.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.6 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.3 | 1.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 4.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 8.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 1.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 1.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.3 | 2.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.3 | 2.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 2.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 3.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 1.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.3 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 4.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 2.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.6 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 0.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 1.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 4.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 2.0 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.3 | 0.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 6.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.3 | 1.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 6.5 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.3 | 1.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.3 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 0.5 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 1.6 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 1.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 1.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 1.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.3 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.3 | 0.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 0.3 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.3 | 3.7 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 1.0 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.3 | 0.8 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 2.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.3 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.3 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 0.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.3 | 0.8 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 3.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 0.8 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.3 | 1.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 0.8 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.3 | 1.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 1.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 1.0 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.2 | 1.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.2 | 0.7 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 4.4 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.2 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 4.9 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 3.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.5 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 7.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 1.7 | GO:0090129 | regulation of synapse maturation(GO:0090128) positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.2 | 1.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 2.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 1.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.5 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 6.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.2 | 0.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 1.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 0.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.7 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 0.2 | GO:0048793 | regulation of kidney size(GO:0035564) pronephros development(GO:0048793) |
0.2 | 3.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.9 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.7 | GO:2001268 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 0.4 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 2.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.2 | 0.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 1.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 2.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 2.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.2 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 3.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.4 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 1.5 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 2.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 1.0 | GO:0001840 | neural plate development(GO:0001840) |
0.2 | 1.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 1.9 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 0.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 2.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.2 | 0.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 2.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.4 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 1.4 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 1.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.2 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.2 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 2.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 1.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 2.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 7.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 1.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.4 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 0.6 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.5 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 1.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.4 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.2 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.7 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.4 | GO:0043091 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.2 | GO:0032741 | regulation of interleukin-18 production(GO:0032661) positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 1.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 0.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 5.9 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 0.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.4 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.5 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 0.7 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.9 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.2 | 1.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.3 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 1.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 4.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 0.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.3 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.2 | 0.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.3 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 1.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.2 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.2 | 0.2 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.2 | 1.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.5 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 2.3 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.2 | 0.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 2.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 2.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 0.5 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.3 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 5.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 1.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 1.9 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 1.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.3 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 1.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 0.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.4 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 4.5 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.3 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 2.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 1.7 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.3 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.6 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 1.2 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.1 | 0.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 1.0 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 1.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 8.3 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 2.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 1.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 1.3 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.1 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.4 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.1 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.2 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.1 | 0.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 1.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 1.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 1.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 1.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 1.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 2.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.4 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 1.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.8 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 0.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.5 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.1 | 3.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 1.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 1.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.3 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 2.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.9 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 3.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.1 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
0.1 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.6 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0051305 | meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 1.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 2.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.3 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.8 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.4 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0070562 | vitamin D receptor signaling pathway(GO:0070561) regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 0.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 0.2 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.1 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.3 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 1.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.1 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.8 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 2.8 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 1.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.3 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.1 | 0.1 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.7 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.1 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.4 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 1.1 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.3 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.2 | GO:0048512 | circadian behavior(GO:0048512) |
0.0 | 0.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.3 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 1.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 1.2 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.3 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 1.0 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 1.5 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.0 | 0.5 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.0 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.3 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.2 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 1.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.3 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.1 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 1.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.6 | GO:0015758 | glucose transport(GO:0015758) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.4 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.3 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.0 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.0 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0071599 | otic vesicle development(GO:0071599) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.0 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 0.0 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.8 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.4 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.0 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.0 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.1 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.9 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.0 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.0 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.0 | 0.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0097443 | sorting endosome(GO:0097443) |
1.7 | 10.5 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.6 | 9.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.2 | 5.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.1 | 4.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 3.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.1 | 3.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 2.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 8.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.9 | 7.0 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 2.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.9 | 6.1 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 1.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.9 | 2.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 12.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.8 | 2.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.8 | 3.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 10.1 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 2.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 4.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 2.2 | GO:0097413 | Lewy body(GO:0097413) |
0.7 | 3.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.7 | 2.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.7 | 2.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 2.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 2.5 | GO:0035363 | histone locus body(GO:0035363) |
0.6 | 33.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 2.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 1.2 | GO:0044393 | microspike(GO:0044393) |
0.6 | 2.2 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 1.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 4.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 2.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 1.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 8.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 3.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 2.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 2.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 2.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.5 | 4.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 1.4 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 2.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 1.7 | GO:0031430 | M band(GO:0031430) |
0.4 | 3.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 1.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 2.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 4.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 1.6 | GO:0031672 | A band(GO:0031672) |
0.4 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 10.2 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 0.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 2.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 3.9 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.3 | 2.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 1.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 5.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 0.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 0.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 5.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.6 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 0.9 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 1.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 2.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 2.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 3.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 1.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 2.3 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 4.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 3.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 11.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 3.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 1.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 69.6 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 2.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 9.6 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 3.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 3.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 8.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.7 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 14.8 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 1.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 10.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 2.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 3.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 4.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 8.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 1.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 2.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.9 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 6.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 6.5 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 2.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 2.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 7.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.2 | GO:0030669 | endocytic vesicle membrane(GO:0030666) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.2 | 41.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 5.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 4.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 6.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 2.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 2.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 4.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 10.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 3.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 3.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 2.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 7.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 4.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.4 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 1.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 2.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 2.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 2.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 1.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 4.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 4.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 9.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 3.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 2.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 6.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 43.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) nuclear replisome(GO:0043601) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 1.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 3.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 3.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 2.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 1.5 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 2.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.2 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.9 | 5.7 | GO:0030172 | troponin C binding(GO:0030172) |
1.6 | 6.6 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 5.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.3 | 3.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.3 | 10.1 | GO:0008430 | selenium binding(GO:0008430) |
1.2 | 14.7 | GO:0017166 | vinculin binding(GO:0017166) |
1.2 | 3.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 3.6 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 10.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.1 | 13.2 | GO:0044548 | S100 protein binding(GO:0044548) |
1.1 | 3.3 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.0 | 4.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 3.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.9 | 2.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 2.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.9 | 11.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 2.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 10.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 2.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.8 | 2.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.8 | 4.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.7 | 11.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.7 | 2.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 3.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 4.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 5.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 2.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.7 | 2.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 4.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 3.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.7 | 2.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 11.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 1.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 2.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.6 | 2.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 3.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.6 | 6.4 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 1.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 2.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 2.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 2.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 3.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.5 | 2.7 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 3.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 3.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 2.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 1.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 3.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 4.7 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 1.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 6.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 6.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 2.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 2.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.5 | 2.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 5.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 5.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.5 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.5 | 5.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 5.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 4.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 4.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 0.9 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.4 | 1.3 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 12.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 1.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 3.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 3.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 2.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 22.3 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 1.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 2.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 4.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 0.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 5.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 2.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.4 | 1.2 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 1.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 2.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 3.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 1.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 1.0 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 5.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 10.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 1.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 10.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 1.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 4.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 3.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 3.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 2.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 1.2 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.2 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 5.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 2.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 2.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 5.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 0.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.8 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 2.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 2.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 9.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 0.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 0.8 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 17.6 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.0 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 3.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.7 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 5.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 2.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 1.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 1.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 19.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.5 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 2.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 2.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 1.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 5.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 2.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 17.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 1.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 2.7 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 1.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.4 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.2 | 0.8 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 1.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 2.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 1.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 5.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 2.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 4.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 3.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 3.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 2.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 2.6 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 2.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 2.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 3.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.2 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.9 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.5 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.0 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 5.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.6 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.5 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 4.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 1.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 2.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 42.7 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.1 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.4 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 1.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 6.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 5.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 1.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 2.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 3.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 1.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 2.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 6.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 3.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 3.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 2.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.2 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.7 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 3.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 4.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 3.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.2 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 12.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 3.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 2.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 2.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 3.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 3.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 4.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 3.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 6.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 2.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 1.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 3.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 2.5 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 7.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 4.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 1.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 2.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.3 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 4.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 2.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 1.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 1.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.0 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.0 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.4 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 4.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 1.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 1.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.5 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.5 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 1.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 7.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 5.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 16.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 3.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 12.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 7.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 19.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 1.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 11.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 4.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 7.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 5.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 3.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 5.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 4.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 2.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 11.6 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 2.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 5.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 3.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 7.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 5.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 7.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 14.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 3.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 9.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 12.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 2.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 5.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 5.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 2.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 4.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 3.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 4.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 3.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 7.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 3.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 42.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 6.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 2.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 27.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 4.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 5.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 4.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 6.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 2.9 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 1.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 6.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 3.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 17.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 7.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 3.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 8.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.0 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.2 | 11.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.0 | 2.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 3.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.6 | 6.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 15.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 15.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 11.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 7.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 5.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 4.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 4.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 9.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 7.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 3.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 9.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 12.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 4.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.4 | 3.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 2.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 4.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 26.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 1.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 2.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 7.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 1.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 1.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 1.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 1.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 5.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 4.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 3.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 2.7 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 5.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 2.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 5.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 26.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 2.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 1.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 1.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 2.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 5.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 3.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 4.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 2.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 5.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 1.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 2.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 2.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 7.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 6.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 3.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 2.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.5 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 2.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 2.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 5.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 3.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 8.9 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 4.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.0 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 2.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |